Most Read News

Indian stock market extended its losing streak on July 23, 2026, with the Sensex falling 363 points and the Nifty closing below 23,900. Escalating US-Iran tensions, higher crude oil prices, persistent FII selling, and weak global sentiment weighed on markets, while the Auto sector emerged as the lone outperformer.

Global markets witnessed sharp volatility as escalating Middle East tensions pushed Brent crude above $100 per barrel and sent US markets down over 2%. Rising bond yields, inflation concerns, FII selling, and crude oil risks are key factors Indian investors need to monitor.

The Xtranet Technologies IPO is open for subscription from 23 to 27 July 2026. While the latest Grey Market Premium (GMP) has fallen to ₹7 from ₹26, investors are closely tracking the expected listing gains, subscription response, and overall IPO outlook.

Motilal Oswal Financial Services (MOFSL) posted a strong recovery in Q1FY27 net profit, aided by treasury gains and record AUM. Despite the impressive headline numbers, concerns over weak core operating performance and rising costs dragged the stock more than 9% lower.

HDFC Bank shares fell 7.55% over the past week as disappointing Q1 FY27 earnings, margin pressure, and investigations by three US law firms over alleged ₹45 crore MSRDC payments weighed on investor sentiment. The bank has denied all allegations, while the RBI said it found no material governance concerns.

IndiGo has postponed salary increments for senior management after reporting a quarterly loss of ₹238 crore in Q1 FY27. Despite strong revenue growth, higher fuel costs and margin compression impacted profitability, while InterGlobe Aviation shares declined around 2% following the results.

Caliber Mining and Logistics Ltd made a strong stock market debut, listing at ₹500.25 against its IPO price of ₹424. Backed by a massive 154.66x subscription and healthy GMP of ₹60–₹115, the stock climbed to an intraday high of ₹510 on listing day.

The Nifty Smallcap 250 TRI has experienced sharp corrections far more frequently than the Nifty 50, highlighting the risks and opportunities of small-cap investing. Here's what 20 years of historical data reveals about market timing, lump-sum investing, SIPs, and long-term wealth creation.

Dr. Reddy's Laboratories stock fell nearly 7% to a fresh 52-week low of ₹1,101 after reporting disappointing Q1 FY27 earnings. A sharp decline in profit, weaker North America sales, margin compression, Semaglutide API quality issues, and cautious analyst commentary triggered heavy selling in the pharma stock.

Swiggy shares came under sharp selling pressure after the company proposed capping foreign ownership at 49.5%. The move has sparked concerns over potential exclusion from MSCI and FTSE indices, with analysts estimating passive outflows of nearly $500 million despite the company's long-term quick commerce strategy.